Tim Kilgallon
CEO at Ideal Option Addiction Medicine Program
Tim Kilgallon is CEO at Ideal Option Addiction Medicine Program. He previously co-founded Mazlo and served as a board member at Arivale, Chrono Therapeutics, and EXOS, as well as an associate at King & Spalding.
-
Ideal Option Addiction Medicine Program CEO 2019–present · current
-
WellAir CEO 2017–2018 · past
-
Arivale Board Member 2014–2019 · past
-
Chrono Therapeutics Board Member 2014–2019 · past
-
Mazlo Co-founder and CEO 2013–2017 · past
-
Polaris Venture Partners CEO-in-Residence 2013–2014 · past
-
EXOS Board Member 2011–2018 · past
-
King & Spalding Associate 1986–1988 · past
-
O'Callaghan, Saunders & Stumm Associate 1984–1986 · past
Education
-
Washington and Lee University School of Law Doctor of Law (JD) · 1981–1984
-
Boston College Bachelor of Science (BS), Economics and Philosophy · 1977–1981
-
Wootton High School 1973–1977
Organizations
See all 9-
Ideal Option Addiction Medicine Program CEO 2019–present · current
-
WellAir CEO 2017–2018 · past
-
Arivale Board Member 2014–2019 · past
Education
-
Washington and Lee University School of Law Doctor of Law (JD) · 1981–1984
-
Boston College Bachelor of Science (BS), Economics and Philosophy · 1977–1981
-
Wootton High School 1973–1977
